Letter Re: Butyrylcholinesterase is a potential biomarker for sudden infant death syndrome

EBioMedicine. 2022 Aug:82:104171. doi: 10.1016/j.ebiom.2022.104171. Epub 2022 Jul 15.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Biomarkers
  • Butyrylcholinesterase
  • Humans
  • Infant
  • Sudden Infant Death* / diagnosis
  • Sudden Infant Death* / etiology
  • Syndrome

Substances

  • Biomarkers
  • Butyrylcholinesterase